Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Thank you. So good afternoon, everyone, and thank you very much for joining our session with Bristol-Myers. My name is Dave Risinger. I cover both major and specialty pharmaceuticals at Morgan Stanley.
Before we get started, I need to refer you to a disclaimer. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. It's not for members of the press. If you're a member the press, please disconnect and reach out separately. For important disclosures, please see www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
So I wanted to welcome Giovanni Caforio, who is the CEO and Chairman of Bristol-Myers. He became CEO in 2015, originally joined Bristol in 2000 as a VP and General Manager. He took on positions of increasing responsibility, eventually
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |